Analytical evaluation threshold | Materials Metric

The analytical evaluation threshold (AET) is a calculated concentration limit that defines the minimum level at which an analytical method must reliably detect and quantify chemical substances in extractables and leachables studies. At Materials Metric, we help engineers and regulatory professionals apply this threshold accurately to ensure product safety and compliance.

Understanding the AET is essential for anyone conducting chemical characterization of materials used in medical devices, pharmaceutical packaging, or drug delivery systems. Furthermore, it directly determines which analytical techniques to deploy and at what sensitivity. Consequently, selecting the right methods from the outset saves time, reduces cost, and strengthens regulatory submissions.

In practice, the AET bridges toxicology and analytical chemistry. Specifically, it converts a toxicological concern threshold into a measurable analytical target. Moreover, regulatory frameworks such as ISO 10993-18 Chemical Characterization and USP guidelines require laboratories to demonstrate that their methods can detect substances at or below this critical level.

Key Takeaways

• The analytical evaluation threshold sets the minimum detection sensitivity required for extractables and leachables testing.
• It derives directly from toxicological concern thresholds and patient safety exposure limits.
• Regulatory bodies including ISO and USP mandate AET compliance for medical device and pharmaceutical materials.
• Laboratories must validate that their methods can reliably quantify substances at or below the AET.
• Choosing the correct analytical techniques depends entirely on whether their detection limits fall below the AET.
• A well-calculated AET protects patients, reduces regulatory risk, and streamlines approval timelines.

Analytical Evaluation Threshold (AET): A calculated concentration value, derived from a safety-based concern threshold, that specifies the minimum detection and quantification capability an analytical method must achieve to ensure all toxicologically relevant extractables and leachables are identified in a chemical characterization study.

Key fact: Failing to meet the analytical evaluation threshold is one of the leading reasons regulatory agencies issue deficiency letters for chemical characterization submissions in medical device and pharmaceutical applications.

What Is the Analytical Evaluation Threshold and Why Does It Matter?

The analytical evaluation threshold represents a safety-driven detection target. Essentially, it asks: “If a harmful chemical were present at a toxicologically concerning level, would your analytical method catch it?” Therefore, it sets the floor for method sensitivity rather than the ceiling for acceptable contamination.

Regulatory reviewers use the AET to judge whether a laboratory’s analytical data is scientifically credible. Specifically, if a method cannot detect substances at or below the AET, the resulting data may not adequately protect patients. In addition, such gaps can trigger requests for additional testing, delaying product approval significantly.

How the AET Differs from a Safety Threshold

Many professionals confuse the AET with the tolerable intake (TI) or the threshold of toxicological concern (TTC). However, these are distinct values that serve different purposes. The TTC or TI defines the maximum dose a patient can safely receive. By contrast, the AET converts that dose into an analytical concentration target, accounting for dose calculations, worst-case scenarios, and extraction efficiencies.

For example, if a patient’s tolerable daily intake for a substance is 1.5 µg/day, the AET might calculate to a concentration of 0.15 µg/mL in an extract. Consequently, the laboratory must prove its methods can detect and quantify that substance at 0.15 µg/mL or lower. Moreover, this calculation must account for material mass, extraction volume, and the number of devices or doses administered per day.

The Regulatory Drivers Behind AET Requirements

Several major regulatory frameworks mandate the use of the AET. ISO 10993-18 Chemical Characterization explicitly requires manufacturers to establish an AET before conducting extractables studies on medical device materials. Similarly, the USP General Chapter <232> Elemental Impurities framework establishes concentration limits that function analogously to AET requirements for inorganic substances.

Additionally, the PQRI (Product Quality Research Institute) Leachables and Extractables Working Group has published widely cited guidance on AET calculation for orally inhaled and nasal drug products. Importantly, these frameworks collectively signal that the AET is not optional — it is a cornerstone of defensible chemical characterization. Furthermore, our team at Materials Metric integrates these requirements into every Chemical & Analytical Testing engagement from the project planning stage.

How to Calculate the Analytical Evaluation Threshold

Calculating the AET requires a systematic, multi-step approach. Importantly, the calculation must be traceable, documented, and scientifically defensible for regulatory submission. Furthermore, each variable in the formula must reflect worst-case patient exposure assumptions to ensure the most conservative — and therefore safest — outcome.

Step 1 — Establishing the Toxicological Concern Threshold

The process begins with identifying the appropriate safety threshold. Most chemical characterization studies use the Threshold of Toxicological Concern (TTC), which is a conservative, structure-based exposure limit for unstudied or unknown chemicals. Specifically, the TTC for non-genotoxic substances is commonly set at 1.5 µg/day per Cramer Class I, though higher-risk classifications carry lower limits.

For device-specific studies, the tolerable intake (TI) may instead derive from substance-specific toxicological data. In addition, our toxicological risk assessment services help clients determine the most appropriate starting threshold for each substance class. Moreover, using the wrong threshold can result in either over-testing (wasting resources) or under-testing (creating safety gaps).

Step 2 — Applying Dose and Exposure Adjustments

Next, the laboratory must apply dose-related correction factors. These factors include the maximum daily dose of the product, the number of units a patient uses per day, and any relevant surface-area-to-extract-volume ratios. Consequently, the AET expressed as a concentration in an extract will differ from the raw TTC value by one or more orders of magnitude.

For example, a single-use injection device administered once daily yields a different AET than a reusable respiratory device used multiple times per day. Therefore, the exposure scenario must be carefully defined before finalizing the AET. Our Scientific & Technical Consulting team routinely assists clients in defining these scenarios accurately and conservatively.

Step 3 — Converting to an Analytical Concentration Target

The final calculation step converts the adjusted safety threshold into a concentration value within the extraction solution that the analytical method must detect. Specifically, this requires knowledge of the extraction volume used during sample preparation. Furthermore, the resulting AET concentration becomes the benchmark against which the method’s limit of quantitation (LOQ) is compared.

If the method’s LOQ exceeds the AET, the method fails to meet the analytical evaluation threshold requirement. In that case, the laboratory must either improve method sensitivity or adopt an alternative technique. For instance, switching from standard UV-HPLC to GC-MS Analysis or HPLC Analysis with a more sensitive detector may be necessary to achieve compliance.

Selecting Analytical Methods That Meet the Analytical Evaluation Threshold

Once laboratories establish the AET, they must select analytical techniques with sufficient sensitivity. Moreover, no single technique covers all chemical classes. Therefore, a comprehensive extractables study typically requires a battery of complementary methods, each validated to demonstrate performance at or below the analytical evaluation threshold.

Chromatographic and Spectroscopic Techniques

Chromatographic methods form the backbone of most extractables and leachables studies. GC-MS Analysis excels at detecting volatile and semi-volatile organic compounds at sub-µg/mL concentrations. Similarly, HPLC Analysis paired with mass spectrometry or UV detection covers a wide range of non-volatile organic substances.

Spectroscopic techniques complement chromatographic data by providing structural confirmation. For example, FTIR Analysis and Raman Spectroscopy identify functional groups in extractables, while NMR Spectroscopy offers unambiguous structural elucidation for unknown compounds. Consequently, combining these techniques ensures that no analytically significant substance goes unidentified.

Elemental and Surface Analysis Techniques

Inorganic extractables — particularly metals and trace elements — require dedicated elemental analysis methods. XRF Analysis provides rapid elemental screening across a broad mass range, making it useful for initial survey testing. Furthermore, XPS Analysis characterizes elemental oxidation states at material surfaces, which is particularly relevant for implantable device coatings and surface-treated polymers.

For morphological context, SEM Analysis combined with energy-dispersive X-ray spectroscopy (EDS) can localize and semi-quantify elemental hotspots in particulate extractables. Meanwhile, TEM Analysis provides nanoscale resolution for ultra-fine particles that may not be visible by SEM. Together, these techniques support a thorough Chemical & Elemental Characterization profile that satisfies regulatory reviewers.

Method Validation Against the AET

Selecting a capable technique is only the first step. Importantly, laboratories must also validate that the method performs reliably at the AET concentration. This validation process includes demonstrating accuracy, precision, specificity, and — most critically — a limit of quantitation (LOQ) at or below the AET.

Our Method Development & Validation services provide the documentation required to satisfy both internal quality standards and external regulatory expectations. Specifically, we generate full method validation reports that include LOQ confirmation at the AET, spike-and-recovery data, and matrix interference assessments. Furthermore, these reports align with ICH Q2(R1) guidelines and ISO 10993-18 requirements, ensuring broad regulatory acceptance.

A structured comparison of common analytical methods and their typical detection capabilities relative to the AET is shown in the table below.

Quick note: When a standard technique’s LOQ exceeds the analytical evaluation threshold, upgrading to a hyphenated mass spectrometry method or adopting a pre-concentration sample preparation step typically resolves the gap without requiring a complete study redesign.

In addition to chromatographic and elemental methods, Chemical Purity & Contaminant Screening studies often incorporate Wet Chemistry & Classical Analytical Methods for non-specific parameters such as total organic carbon (TOC), pH, and residue on ignition. Moreover, these classical endpoints provide additional safety assurance even when they do not directly address the AET in the same way that targeted chemical methods do. Consequently, a well-designed study plan integrates both targeted and non-specific analyses to deliver a comprehensive safety profile. For device-specific programs, Biocompatibility & Toxicity Testing may also be required alongside chemical characterization to complete the biological evaluation, as described in our related guidance on FDA chemical characterization review.

Furthermore, referring to current literature helps teams stay aligned with evolving best practices. Resources such as ScienceDirect – Analytical Methods and PubMed Central – Trace Metals Review provide peer-reviewed data on method sensitivity and chemical characterization strategies that directly inform AET-compliant study design. Additionally, Nature Reviews Methods Primers offers accessible primers on advanced analytical techniques relevant to extractables and leachables science.

Advanced Elemental Analysis Techniques for Analytical Evaluation Threshold Compliance

Elemental extractables often present the greatest sensitivity challenge in AET-compliant studies. Fortunately, modern atomic spectrometry methods deliver detection limits well below most calculated AET values. Therefore, selecting the right elemental technique depends on the number of target elements, required sensitivity, and matrix complexity.

ICP-MS: The Gold Standard for Trace Elemental Detection

Inductively coupled plasma mass spectrometry (ICP-MS) remains the most powerful tool for meeting the analytical evaluation threshold in elemental analysis. Specifically, ICP-MS achieves detection limits in the parts-per-trillion (ppt) range, far exceeding what most AET calculations require. Furthermore, it simultaneously measures dozens of elements in a single run, making it highly efficient for multi-element extractables screening.

ICP-MS is particularly well-suited for regulated applications governed by USP Elemental Impurities limits for elements such as lead, arsenic, cadmium, and mercury. Consequently, pharmaceutical packaging and medical device manufacturers routinely rely on ICP-MS to satisfy both AET requirements and elemental impurity limits simultaneously. Moreover, collision cell and reaction cell technologies in modern ICP-MS instruments resolve common polyatomic interferences, improving data reliability in complex extract matrices.

ICP-OES and AAS as Complementary Elemental Methods

Inductively coupled plasma optical emission spectrometry (ICP-OES) offers slightly higher detection limits than ICP-MS but delivers excellent precision for higher-concentration elemental work. Additionally, ICP-OES handles high-matrix samples more robustly, making it a practical choice when extract concentrations are elevated or sample volumes are limited.

Atomic absorption spectrometry (AAS), including graphite furnace AAS (GFAAS), provides single-element analysis at very low concentrations. By contrast, AAS is slower than ICP-based methods for multi-element panels. However, GFAAS remains valuable for specific elements where ICP interference is problematic. Together, these three elemental techniques — ICP-MS, ICP-OES, and GFAAS — form a complementary toolkit for Chemical & Elemental Characterization across all AET levels.

Crystallographic and Phase Analysis Support

Beyond solution-phase elemental analysis, some extractables programs require solid-state characterization. For instance, particulate matter extracted from device components may contain crystalline inorganic phases that standard solution methods cannot fully identify. In such cases, XRD Analysis identifies the crystal structure and phase composition of particulate extractables, providing critical context for risk assessment.

Similarly, DSC Testing characterizes thermal transitions in polymeric materials, which can signal degradation products relevant to the extractables profile. Furthermore, understanding thermal behavior helps predict which compounds might leach under elevated processing or sterilization temperatures. Consequently, incorporating these complementary techniques into a comprehensive study design ensures that the analytical evaluation threshold is met across all relevant chemical forms.

Industry-Specific Applications of the Analytical Evaluation Threshold

The AET concept applies across multiple industries, though the specific calculation inputs and regulatory frameworks differ. Moreover, each sector carries unique exposure scenarios that fundamentally shape the AET value and the analytical approach required.

Pharmaceutical Packaging and Drug Delivery Systems

Pharmaceutical applications represent the most mature regulatory environment for AET-based chemical characterization. Specifically, container closure systems — including vials, stoppers, syringes, and IV bags — must demonstrate extractables profiles that fall within toxicologically acceptable limits. The AET calculation in this context accounts for drug product contact surface area, fill volume, storage duration, and patient dosing frequency.

Regulatory submissions to the FDA and EMA increasingly require AET documentation as part of the Chemistry, Manufacturing, and Controls (CMC) section. Therefore, pharmaceutical companies must partner with laboratories experienced in AET-driven study design. Our Chemical & Analytical Testing team designs these studies from first principles, ensuring the analytical evaluation threshold is correctly established before any sample analysis begins.

Medical Devices and Implantable Materials

Medical device manufacturers face AET requirements under ISO 10993-18, which explicitly mandates AET calculation as part of the chemical characterization process. Furthermore, the biological evaluation plan (BEP) must reference the AET to justify the scope and sensitivity of analytical testing. Devices with direct blood contact or implantable components carry the most stringent AET values because patient exposure is prolonged and systemic.

Surface coatings, adhesives, lubricants, and colorants in medical devices all contribute to the extractables profile. Importantly, each material component may require a separate AET-driven analysis. Our related guidance on FDA chemical characterization review provides additional context on how device manufacturers should structure their submissions to meet these requirements efficiently.

Aerospace, Industrial, and Environmental Applications

Beyond life sciences, the AET principle extends to aerospace materials qualification, food-contact packaging, and environmental monitoring. In aerospace, materials in crew compartments or fluid systems may off-gas volatile organic compounds at levels requiring AET-analogous detection thresholds. Similarly, food-contact material regulations in the EU and US set migration limits that function as de facto analytical evaluation thresholds.

Environmental testing programs use threshold-based detection targets to monitor trace contaminants in water, soil, and air. Consequently, the underlying concept of setting method sensitivity based on a health-protective limit is universal, even when the specific regulatory label differs. Furthermore, our Scientific & Technical Consulting team regularly adapts AET methodology to non-traditional contexts, helping clients in diverse industries establish defensible detection targets for their specific applications.

Quality Assurance and Best Practices for Analytical Evaluation Threshold Studies

Achieving AET compliance is not solely a technical challenge. Moreover, it demands rigorous quality assurance practices at every stage, from study planning through data reporting. Therefore, laboratories must embed quality controls into the analytical workflow to produce data that withstands regulatory scrutiny.

Establishing a Robust Study Plan Before Testing Begins

Every AET-compliant study should begin with a written analytical study plan. This document must define the AET value, the rationale for its calculation, the extraction conditions, and the analytical methods selected. Furthermore, the plan should identify acceptance criteria for method performance, including the required LOQ relative to the AET.

Regulators increasingly expect this documentation to accompany submission packages. Specifically, the ISO 10993-18 standard references a “chemical characterization report” that captures all of these elements. Importantly, starting without a formal plan is one of the most common causes of study failure — and subsequent regulatory deficiency notices. Our Method Development & Validation team helps clients build these plans with the precision and foresight that regulatory reviewers expect.

System Suitability and Reference Standards

System suitability testing ensures that the analytical instrument performs within acceptable limits at the time of analysis. Consequently, analysts run system suitability checks before every analytical sequence to confirm that sensitivity, resolution, and repeatability meet the required specifications. Additionally, certified reference standards must be traceable to NIST or equivalent national metrology institutes.

Blank controls, matrix-matched calibration standards, and spiked recovery samples all form essential parts of the quality control framework. By contrast, studies that rely on solvent-only calibration without matrix matching frequently show recovery biases that can cause substances to appear absent when they are actually present at or near the AET. Furthermore, our laboratory team applies these controls rigorously across all Chemical & Analytical Testing programs to ensure data integrity from the first injection to the final report.

Documentation, Data Integrity, and Regulatory Reporting

Regulatory agencies place enormous weight on data integrity. Therefore, all raw data, instrument logs, and analyst records must be maintained in a traceable audit trail. Additionally, electronic laboratory notebooks (ELNs) and validated LIMS systems help ensure that no analytical result can be altered without a documented record.

The final chemical characterization report must clearly demonstrate that every identified substance was detected at a concentration relative to the analytical evaluation threshold. Specifically, the report should state whether each substance is above, below, or not detected relative to the AET, and it should explain the implications for safety and regulatory compliance. Moreover, findings above the AET trigger further toxicological evaluation, which our team coordinates through integrated Biocompatibility & Toxicity Testing services.

Quick note: Regulatory reviewers specifically look for a clear, one-to-one mapping between each detected substance, its measured concentration, and its relationship to the analytical evaluation threshold. Studies that present data without this mapping are the most common recipients of information requests from agencies such as the FDA and notified bodies.

For teams navigating complex regulatory landscapes, resources published on ScienceDirect provide peer-reviewed methodological support for building defensible AET-compliant analytical programs. Additionally, consulting published guidance from international harmonization bodies ensures that study designs meet expectations across multiple regulatory jurisdictions simultaneously.

Frequently Asked Questions About Analytical Evaluation Threshold (AET)

What is the difference between the AET and the qualification threshold?

The analytical evaluation threshold (AET) defines the minimum sensitivity an analytical method must achieve. By contrast, the qualification threshold (QT) is the concentration above which a detected extractable must be formally toxicologically qualified. Therefore, these two values serve complementary but distinct purposes — the AET governs analytical method performance, while the QT governs the toxicological response to detected substances.

Does every extractables study require a formal AET calculation?

Yes — for studies governed by ISO 10993-18 or ICH Q3E-equivalent guidance, a formal AET calculation is mandatory. Specifically, the AET must be documented and referenced throughout the study to justify the sensitivity of methods selected. Furthermore, regulatory reviewers routinely check that the stated LOQs fall at or below the calculated AET before accepting chemical characterization data.

Can a single analytical technique meet the AET for all substance classes?

No single technique covers all chemical classes at the required sensitivity. Consequently, most extractables studies require a combination of chromatographic, spectroscopic, and elemental methods. For instance, GC-MS handles volatile organics, LC-MS/MS addresses non-volatile organics, and ICP-MS covers elemental impurities — each operating well below typical AET values for their respective analyte classes.

What happens when a detected substance exceeds the AET?

Detection above the AET does not automatically indicate a safety concern. However, it does trigger a structured toxicological evaluation. Specifically, the detected substance must be identified, its concentration quantified accurately, and a substance-specific risk assessment conducted. Our integrated Biocompatibility & Toxicity Testing services manage this escalation pathway efficiently, ensuring that no safety concern goes unaddressed in the final submission package.

How does the AET change for different patient populations or exposure routes?

The AET varies significantly based on the patient population and the route of administration. For example, parenteral (intravenous) routes yield much lower AET values than topical routes because bioavailability is near 100%. Moreover, pediatric patients or immunocompromised individuals may warrant more conservative safety thresholds, further lowering the AET. Therefore, exposure-route-specific AET calculations are essential and must reflect the actual intended clinical use of the product or device.

How often should AET calculations be reviewed and updated?

Teams should review the AET whenever key study parameters change. Specifically, changes in product formulation, device design, sterilization method, or intended patient population may all alter the exposure scenario and consequently shift the AET. Furthermore, updates to regulatory guidance — such as new ISO 10993-18 annexes or revised USP chapters — may introduce new calculation requirements. Our Scientific & Technical Consulting team regularly assists clients in auditing and refreshing existing AET calculations to maintain compliance as regulations evolve.

Conclusion

The analytical evaluation threshold is far more than a regulatory checkbox. Fundamentally, it is the scientific bridge between toxicology and analytical chemistry that ensures chemical characterization studies genuinely protect patients. Furthermore, a correctly calculated and rigorously applied AET strengthens regulatory submissions, reduces the risk of deficiency letters, and accelerates product approval timelines.

Achieving compliance requires the right combination of analytical techniques, validated methods, quality controls, and regulatory expertise. Moreover, the AET must be revisited whenever product parameters or regulatory guidance changes. Consequently, building a long-term partnership with an experienced analytical laboratory is the most efficient way to maintain continuous compliance.

At Materials Metric, our multidisciplinary team integrates toxicological expertise, advanced instrumentation, and deep regulatory knowledge to deliver AET-compliant chemical characterization programs across pharmaceutical, medical device, and industrial applications. Specifically, we cover everything from study design and method validation through final report preparation and regulatory response support. Additionally, our scientists stay current with evolving ISO, USP, and FDA guidance to ensure every program reflects the latest expectations.

If your organization needs support establishing or verifying an analytical evaluation threshold, designing an extractables and leachables study, or validating analytical methods to meet regulatory sensitivity requirements, we are ready to help. Contact Materials Metric today to discuss your specific project requirements and discover how our expertise can support your path to regulatory clearance.

Related Posts from Materials Metric

Explore more insights from our team of materials scientists and analytical experts:

• Toxicological risk assessment | Materials Metric
• FDA chemical characterization review | Materials Metric
• Biological evaluation plan | Materials Metric | Compliance
• ISO 10993-1:2025 changes | Materials Metric | Compliance